Notwithstanding these discrepant findings of the role of IFN-I signaling in ICB resistance between these two studies, both indicated that deletion of IFNAR1 in tumor cells may not mediate primary resistance to ICBs. This evidence concerns the gene IFNAR1 and neoplasm.